Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.770 | 0.770 | 0.000 |
Stocks | 99.230 | 99.230 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.240 | 21.770 |
Price to Book | 3.393 | 3.989 |
Price to Sales | 1.112 | 2.260 |
Price to Cash Flow | 13.583 | 16.880 |
Dividend Yield | 2.067 | 1.345 |
5 Years Earnings Growth | 8.746 | 11.341 |
Number of long holdings: 35
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
GSK plc DRC | US37733W2044 | 5.75 | 41.35 | +1.15% | |
Eli Lilly | US5324571083 | 5.58 | 832.59 | +0.16% | |
Sanofi | FR0000120578 | 5.24 | 90.69 | +0.47% | |
HCA | US40412C1018 | 5.16 | 332.00 | -0.21% | |
McKesson | US58155Q1031 | 5.03 | 573.73 | +0.10% | |
Roche Holding Participation | CH0012032048 | 5.01 | 236.60 | +1.02% | |
Novo Nordisk B | DK0062498333 | 4.55 | 936.2 | +1.33% | |
Elevance Health | US0367521038 | 4.40 | 540.43 | -0.42% | |
Pfizer | US7170811035 | 4.09 | 29.49 | +0.61% | |
Novartis | CH0012005267 | 4.04 | 94.21 | +1.60% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fondsfinans Norden | 2.92B | 13.62 | 7.86 | - | ||
Fondsfinans Norge | 2.49B | 7.12 | 13.06 | 11.97 | ||
Fondsfinans Aktiv 60/40 | 338.68M | 6.23 | 6.72 | 8.40 | ||
Fondsfinans Global Energi | 203.73M | -1.54 | -4.24 | -2.42 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review